Skip to content
★ Sign in to follow
AM

Anders Martin-Löf

Wilson Therapeutics AB
Total declarations
3
Company
1
▲ Purchases (2 ops.)
€7,952
▼ Sales (1 ops.)
€32k

Latest filing published 29 May 2018 for Wilson Therapeutics AB, €32k.

Filing timeline

BuySale
Anders Martin-Löf

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Anders Martin-Löf: trading record in brief

All filings by Anders Martin-Löf on record concern Wilson Therapeutics AB. In total, 3 filings cover trades dated from 7 December 2016 to 25 May 2018.

On the open market, the record shows 2 purchases worth €7,952 and 1 sale worth €32k. Sales outweigh purchases by €24k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2018: no purchases and 1 sale on the market.

The record was last updated on 29 May 2018 with an open-market sale (€32k) in Wilson Therapeutics AB. The last insider purchase was made public on 7 December 2016, 3,623 days ago. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Anders Martin-Löf

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▼
    Ekonomi/finanschefExecutivesWilson Therapeutics AB
    324,800 SEK45FI-SE
    1,400 shares@ SEK 232.0079.9% of flowISIN SE0008293674FI:csv-85c6bb93962724766ea8
  • ▲
    Ekonomi/finanschefExecutivesWilson Therapeutics AB
    38,850 SEK32FI-SE
    700 shares@ SEK 55.5010.0% of flowISIN SE0008293674FI:csv-8d24f02dd66f18da1618
    Canonical exit: 7 Mar 2017 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesWilson Therapeutics AB
    39,025 SEK32FI-SE
    700 shares@ SEK 55.7510.1% of flowISIN SE0008293674FI:csv-42ca2218e815d114882e
    Canonical exit: 7 Mar 2017 (T+90)

3 of 3 declarations